GlobeNewswire - Industry News on Health Care Contains the last 20 releases uuid:a94a524d-121d-4aa7-92c7-42451df5a0a9;id=9903 2021-03-06T00:31:39Z newsdesk@globenewswire.com (NewsDesk) http://www.yebxqs.cn/LegacyRss?Length=4 newsdesk@globenewswire.com http://www.yebxqs.cn/news-release/2021/03/06/2188249/0/en/Algernon-Pharmaceuticals-Announces-Increase-and-Close-of-Private-Placement.html Algernon Pharmaceuticals Announces Increase and Close of Private Placement 2021-03-06T00:31:39Z 2021-03-06T01:07:04Z VANCOUVER, British Columbia, March 05, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc.?(CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has increased and completed its previously announced non-brokered private placement of units (the "Units"), and has issued an aggregate of 11,260,040 Units at the price of CDN $0.25 per Unit, raising gross proceeds of CDN $2,815,010 (the “Offering”).

]]>
2188249 en GlobeNewswire Inc. Algernon Pharmaceuticals Sat, 06 Mar 2021 00:32 GMT Stock Market News
http://www.yebxqs.cn/news-release/2021/03/05/2188243/0/en/Adaptive-Biotechnologies-Announces-FDA-Emergency-Use-Authorization-for-T-Detect-COVID-to-Confirm-Recent-or-Prior-COVID-19-Infection.html Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect? COVID to Confirm Recent or Prior COVID-19 Infection 2021-03-05T23:44:57Z 2021-03-06T01:07:04Z First and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19

]]>
2188243 en GlobeNewswire Inc. Adaptive Biotechnologies Fri, 05 Mar 2021 23:45 GMT Health
http://www.yebxqs.cn/news-release/2021/03/05/2188228/0/en/Iterum-Therapeutics-to-Announce-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Host-Conference-Call-on-March-12-2021.html Iterum Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 12, 2021 2021-03-05T22:30:00Z 2021-03-06T01:07:04Z DUBLIN, Ireland and CHICAGO, March 05, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that?the Company will release its fourth quarter and full year 2020 financial results before the open of the?U.S.?financial markets on?Friday, March 12, 2021. Management will host a conference call at?8:30 a.m. ET?that day to discuss the Company’s financial and operational results.

]]>
2188228 en GlobeNewswire Inc. Iterum Therapeutics plc Fri, 05 Mar 2021 22:30 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/05/2188217/0/en/Assembly-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-03-05T22:00:00Z 2021-03-06T01:07:04Z SOUTH SAN FRANCISCO, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced grants of stock options to three new employees to purchase an aggregate of 26,000 shares of the Company’s common stock with an exercise price of $5.05 per share, the closing price of Assembly Bio’s common stock on March 1, 2021. The stock options were granted as material inducements to the new employees to accept the Company’s offers of employment.

]]>
2188217 en GlobeNewswire Inc. Assembly Biosciences, Inc. Fri, 05 Mar 2021 22:00 GMT Stock Market News
http://www.yebxqs.cn/news-release/2021/03/05/2188215/0/en/AnPac-Bio-Regains-Compliance-with-Nasdaq-Continued-Listing-Requirement.html AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement 2021-03-05T21:35:00Z 2021-03-06T01:07:04Z SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that on March 4, 2021, the Company received a letter from the Nasdaq Stock Market, Inc. (“Nasdaq”), stating that for the last 12 consecutive business days, from February 16 to March 3, 2021, the market value of the Company’s listed securities had been $50,000,000 or greater. Accordingly, Nasdaq determined that the Company has regained compliance with Nasdaq Listing Rule 5450(b)(2)(A) (the “Rule”), and this matter has now been closed by Nasdaq.

]]>
2188215 en GlobeNewswire Inc. Anpac Bio, USA Fri, 05 Mar 2021 21:35 GMT Company Announcement Stock Market News disease detection pre-cancer disease biotechnology Cancer Screening early cancer detection multi-cancer detection
http://www.yebxqs.cn/news-release/2021/03/05/2188211/0/en/Flexion-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-03-05T21:30:00Z 2021-03-06T01:07:04Z BURLINGTON, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to four new employees consisting of 14,565 restricted stock units. The Compensation Committee of the Board of Directors approved the grants with an effective date of March 1, 2021. The restricted stock units were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

]]>
2188211 en GlobeNewswire Inc. Flexion Therapeutics, Inc. Fri, 05 Mar 2021 21:30 GMT Company Announcement
http://www.yebxqs.cn/news-release/2021/03/05/2188214/0/en/DBV-Technologies-to-Participate-in-the-H-C-Wainwright-Global-Life-Sciences-Conference.html DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference 2021-03-05T21:30:00Z 2021-03-06T01:07:04Z Montrouge, France, March 5, 2021

]]>
2188214 en GlobeNewswire Inc. DBV Technologies S.A. Fri, 05 Mar 2021 21:30 GMT Other News European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188214/0/fr/DBV-Technologies-invit%C3%A9e-%C3%A0-participer-%C3%A0-la-H-C-Wainwright-Global-Life-Sciences-Conference.html DBV?Technologies invitée à participer à la H.C. Wainwright Global Life Sciences Conference 2021-03-05T21:30:00Z 2021-03-06T01:07:04Z Montrouge, France, le 5 mars (22 h 30),?2021

]]>
2188214 fr GlobeNewswire Inc. DBV Technologies S.A. Fri, 05 Mar 2021 21:30 GMT Other News European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188199/0/en/Apellis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-03-05T21:05:00Z 2021-03-06T01:07:04Z WALTHAM, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals,?Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company approved the grant of equity awards to two new employees with grant date of March 1, 2021, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2021 Inducement Stock Incentive Plan) and material to the employees’ acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

]]>
2188199 en GlobeNewswire Inc. Apellis Pharmaceuticals, Inc. Fri, 05 Mar 2021 21:05 GMT Stock Market News
http://www.yebxqs.cn/news-release/2021/03/05/2188200/0/en/G1-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2021-03-05T21:05:00Z 2021-03-06T01:07:04Z RESEARCH TRIANGLE PARK, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 14,300 shares of G1’s common stock to two employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Inducement Plan”). The stock options were granted as an inducement material to the new employee’s becoming an employee of G1 in accordance with Nasdaq Listing Rule 5635(c)(4).

]]>
2188200 en GlobeNewswire Inc. G1 Therapeutics Fri, 05 Mar 2021 21:05 GMT Stock Market News
http://www.yebxqs.cn/news-release/2021/03/05/2188193/0/en/Lowell-Farms-Inc-Emerges-From-Acquisition-With-an-Eye-Toward-Dominance-in-California-s-Cannabis-Industry-and-Beyond.html Lowell Farms Inc. Emerges From Acquisition With an Eye Toward Dominance in California’s Cannabis Industry and Beyond 2021-03-05T21:00:00Z 2021-03-06T01:07:04Z Formerly Indus Holdings, Inc., cannabis leader completes name change?and lays out strategy for future success]]> 2188193 en GlobeNewswire Inc. Lowell Farms Inc. Fri, 05 Mar 2021 21:00 GMT Mergers and Acquisitions http://www.yebxqs.cn/news-release/2021/03/05/2188187/0/en/Vor-Biopharma-to-Present-at-the-Barclays-Global-Healthcare-Conference.html Vor Biopharma to Present at the Barclays Global Healthcare Conference 2021-03-05T20:00:00Z 2021-03-06T01:07:04Z CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Barclays Global Healthcare Conference, which will take place virtually on March 9-11, 2021.

]]>
2188187 en GlobeNewswire Inc. Vor Biopharma Fri, 05 Mar 2021 20:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/05/2188164/0/en/Celldex-Therapeutics-Announces-Fireside-Chat-Presentation-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html Celldex Therapeutics Announces Fireside Chat Presentation at the H.C. Wainwright Global Life Sciences Conference 2021-03-05T18:00:00Z 2021-03-06T01:07:04Z HAMPTON, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the Company’s participation in a fireside chat at the H.C. Wainwright Global Life Sciences Conference. The presentation for the virtual conference was prerecorded and will be accessible to conference attendees starting on Tuesday, March 9th?2021 at 7:00 a.m. ET.

]]>
2188164 en GlobeNewswire Inc. Celldex Therapeutics, Inc. Fri, 05 Mar 2021 18:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/05/2188142/0/en/Monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-the-share-capital-February-28-2021.html Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2021 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z ????????????????????????????????????????????????????????????????????????????????

]]>
2188142 en GlobeNewswire Inc. Erytech Pharma S.A. Fri, 05 Mar 2021 17:00 GMT Law & Legal Issues European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188142/0/fr/Information-mensuelle-relative-au-nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social-au-28-f%C3%A9vrier-2021.html Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2021 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z ?Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au

]]>
2188142 fr GlobeNewswire Inc. Erytech Pharma S.A. Fri, 05 Mar 2021 17:00 GMT Law & Legal Issues European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188143/0/fr/D%C3%A9claration-d-actions-et-de-droits-de-vote-de-la-soci%C3%A9t%C3%A9-Valneva-SE-F%C3%A9vrier-2021.html Déclaration d'actions et de droits de vote de la société Valneva SE - Février 2021 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z VALNEVA

]]>
2188143 fr GlobeNewswire Inc. VALNEVA Fri, 05 Mar 2021 17:00 GMT Law & Legal Issues European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188145/0/en/EssilorLuxottica-Disclosure-of-Share-Capital-and-Voting-Rights-Outstanding-as-of-February-28-2021.html EssilorLuxottica : Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2021 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z Disclosure of Share Capital and Voting Rights Outstanding
as of February 28, 2021

]]>
2188145 en GlobeNewswire Inc. EssilorLuxottica Fri, 05 Mar 2021 17:00 GMT Changes in share capital and votes European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188145/0/fr/EssilorLuxottica-Nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social-au-28-f%C3%A9vrier-2021.html EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 28 février 2021 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z Nombre total de droits de vote et d’actions
composant le capital social au 28 février 2021

]]>
2188145 fr GlobeNewswire Inc. EssilorLuxottica Fri, 05 Mar 2021 17:00 GMT Changes in share capital and votes European Regulatory News
http://www.yebxqs.cn/news-release/2021/03/05/2188148/0/en/Florida-Veteran-Honored-with-Mobility-Equipped-Vehicle.html Florida Veteran Honored with Mobility-Equipped Vehicle 2021-03-05T17:00:00Z 2021-03-06T01:07:04Z ST. AUGUSTINE, Fla., March 05, 2021 (GLOBE NEWSWIRE) -- Wounded Warriors Family Support presented Brandon Long of St. Augustine, Florida, with a 2021 Ford F-150 XLT mobility-equipped vehicle in late February as part of its Mobility is Freedom program.

]]>
2188148 en GlobeNewswire Inc. Wounded Warriors Family Support Fri, 05 Mar 2021 17:00 GMT Advisory Calendar of Events Politics
http://www.yebxqs.cn/news-release/2021/03/05/2188130/0/fr/Nicox-Assembl%C3%A9es-G%C3%A9n%C3%A9rales-Ordinaire-et-Extraordinaire-2021.html Nicox : Assemblées Générales Ordinaire et Extraordinaire 2021 2021-03-05T16:45:00Z 2021-03-06T01:07:04Z ?

]]>
2188130 fr GlobeNewswire Inc. NICOX Fri, 05 Mar 2021 16:45 GMT Press releases Other News European Regulatory News
粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号